In multiple cancer types, including breast cancer, glioblastoma and melanoma, TGF-β signaling was maintained through canonical and non-canonical pathways and contributed to an upregulation of pro-EMT genes such as ZFGX1a, Slug and Snai1 [81,82,83]. This evidence concerns the gene TGFB1 and breast cancer.